OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Estrogen Receptor Positive Tumor|HER2-negative Breast Cancer|Premenopausal Breast Cancer|Node-positive Breast Cancer
Interventions: DRUG: Ovarian function suppression with endocrine treatments
Sponsor: Gangnam Severance Hospital
Collaborators: Seoul National University